MALIGNANCY

This study compares two materials used to rebuild the chest wall after surgery to remove tumors. Doctors in Pakistan will see if using twisted steel wires works as well as or better than traditional bone cement. They will look at patient pain, breathing ability, complications, an…

This trial is testing if a drug called capmatinib, already used for some lung cancers, can help adults with rare or uncommon cancers that have specific changes in a gene called MET. The goal is to see if the drug shrinks tumors or provides long-term benefit for these hard-to-trea…

This trial is testing if an existing immunotherapy drug called atezolizumab can help control rare cancers or common cancers with rare genetic features. It will involve about 30 adults and children whose cancers have specific genetic markers. The goal is to see if this approved dr…

This trial is testing if a drug called entrectinib, already approved for some lung cancers, can help control other rare cancers that share the same genetic change (called ROS1-positive). It aims to enroll about 30 adults and children with these rare cancers to see if the drug shr…

This study is testing new imaging agents for PET/CT scans to see if they can better detect and monitor cancers of the digestive system, like stomach, colon, and liver cancer. Researchers will give 400 participants a small dose of a radioactive tracer and then perform a full-body …

This study is testing different outreach methods to see which ones work best for increasing African American participation in early-stage cancer treatment trials. Researchers will enroll both cancer patients and their doctors to test different recruitment approaches. The goal is …

This study is creating a national collection of blood and tissue samples from cancer patients who experience serious side effects from immunotherapy drugs. Researchers will collect samples and review medical records to build a resource for future studies. The goal is to help scie…